1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ALIVUS LIFE SCIENCES LTD.
Alivus Life Sciences Ltd. NSE: ALIVUS | BSE: 543322

Alivus Life Sciences Ltd. Live Share Price Today, Share Analysis and Chart

Mid-range Performer
about

Glenmark Life Sciences is primarily engaged in the business of development, manufacture and marketing of active pharmaceutical ingredients.

Read More
1031.10 -19.20 (-1.83%)
54,475
NSE+BSE Volume

NSE 31 Jul, 2025 3:58 PM (IST)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Alivus Life Sciences Ltd. is on 01 Aug 2025 for the purpose of Quarterly Results See details
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Durability score
Medium Financial Strength
40.0 / 100
Valuation Score
Mid Valuation
35.7 / 100
Momentum Score
Technically Neutral
41.2 / 100
Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM
Analyst Price Target
1,294
1Yr Price target upside is 25%
4 analysts

14

S

11

W

6

O

3

T

SWOT Analysis

Alivus Life Sciences Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..
VOTE: Is Glenmark Life Sciences Ltd. worth buying?
131 Votes:
Buy 74.81%
Sell 12.21%
Hold 12.98%
BUY
SELL
HOLD